The final results of the Multicenter Selective Lymphadenectomy Trial (MSLT - 1) that began in 1994 to assess the benefits of sentinel node biopsy for melanoma patients were recently published in the New England Journal of Medicine (NEJM). (sciencedaily.com)
«Moffitt played a pioneering role in the development, testing and teaching of sentinel node biopsy, after the procedure was introduced in 1992,» said Vernon K. Sondak, M.D., chair of Moffitt's Department of Cutaneous Oncology. (sciencedaily.com)
Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world. (sciencedaily.com)